Med Consumer Watch
GLP-1 Drops and Oral Liquid Review 2026: A Lab Tested One. It Was Salty Water.
Back to Articles
Safety13 min readAugust 2, 2026

GLP-1 Drops and Oral Liquid Review 2026: A Lab Tested One. It Was Salty Water.

Every other product we review in this category is a legal supplement making an overreaching claim. This one is different. University chemists put a bottle of GLP-1 oral liquid through analysis and found no GLP-1, no drug of any kind, and a composition indistinguishable from eye drops.

By Med Consumer Watch Team
Search "GLP-1 oral liquid" or "GLP-1 drops" and you enter a different market from the rest of this category. The brand names are strings of letters — STDEI, Zvoevo, Cvreoz, IFMAGIC, Doctia, Honxi, Diapason. The products come in distinctive green boxes. They are sold on Amazon, eBay, AliExpress, TikTok Shop and through a rotating cast of storefronts that appear and disappear. They promise, in various phrasings, an Ozempic-like result in a dropper bottle. We reviewed this category on August 2, 2026. We have no affiliate relationship with anything on this page, and there is nothing here we would take a commission on. Everywhere else in this series we have argued about evidence — whether a trial supports a claim, whether a dose matches a study. That argument does not apply here, because in the one case where somebody put this product in a mass spectrometer, there was nothing in it to argue about. In September 2025, Guardian Australia published the results of a laboratory analysis by chemists at the University of New South Wales. They tested a bottle of "STDEI GLP-1 Weight Loss Oral Liquid," purchased on 23 July 2025 from a site called Maementcurves.com. Dr Jake Violi of UNSW reported that there was "definitely" no GLP-1 and no other identifiable drug molecules in the sample. What the analysis did find was only small concentrations of detectable compounds — preservatives common in cosmetics and some foods, methylparaben and benzenesulfonic acid. The solution was very salty, and appeared to be "simply eye drops or some similar product." His summary: "Luckily, this sample was benign — it's basically salty water. Clearly, the sale of such products is a scam."

What the Analysis Actually Found

It is worth being precise about the finding, because precision is the whole value of it. The UNSW chemists did not conclude that the product was weak, or underdosed, or that its botanical ingredients lacked evidence. Those are the conclusions we reach about legal supplements. They concluded there was no active substance present at all.
  • Claimed | Found
  • GLP-1 / Ozempic-like effect | No GLP-1, no identifiable drug molecules
  • Active therapeutic solution | Small concentrations of methylparaben and benzenesulfonic acid
  • Weight-loss treatment | A salty solution resembling eye drops
  • "Made in Australia" by a family-owned company | Box said "made in the USA"; site operated from overseas
  • FDA approved (per the box) | No FDA-approved GLP-1 exists in oral-drop form

Dr Violi's second point deserves as much attention as the first. He noted that while the preservatives he detected were safe to consume, he was concerned the product "could have contained anything." That is the real hazard. This sample was benign by luck, not by design. There is no quality system, no manufacturing standard and no accountable manufacturer behind a product like this — so the next bottle, from the next storefront, carries no guarantee of being equally harmless. Products sold outside a regulatory framework are not tested for what is in them, and nobody is checking.

The Storefronts Are Built to Disappear

The Guardian's reporting traced how these products are sold, and the pattern matters more than any single brand name, because the brand names are disposable. The seller was a "ghost store." Guardian Australia had previously identified more than 140 sites falsely posing as Australian fashion retailers. The weight-loss products were an expansion of the same infrastructure: storefronts that present as local businesses and are not. The paperwork contradicted itself. Maementcurves.com claimed the solution was made in Australia by a local, family-owned company. The box that arrived said it was made in the USA and approved by the US Food and Drug Administration. The return address was an office tower in Sydney's central business district. A second site, Greatrfg.com, flew an Australian flag banner and sold a "GLP-1 Oral Solution For Weight Reduction," claiming approval by Australia's Therapeutic Goods Administration. Its own terms of service named the operator as Hamjouy Limited, a company in Hong Kong. An attempt to contact it produced a bounce-back saying the "remote server is misconfigured." And the page vanished when questioned. After Guardian Australia contacted Maementcurves.com for comment, the weight-loss section of the site appeared to be taken down. This is why we are not going to tell you which of these brands to avoid by name. The name is the most disposable part of the operation. A storefront that gets attention closes and reopens under a new string of letters. What persists is the pattern, and the pattern is recognisable.

The green box is the most useful single tell. Guardian Australia reported that these "weight-loss drops" come in distinctive green packaging and are readily available across eBay, Amazon and AliExpress under many different brand names. When the same physical product appears under a dozen unrelated brands, you are not looking at a dozen companies. You are looking at one commodity item with a dozen labels, and no one of them is accountable for what is inside.

The Testimonials Were Stolen People

The advertising apparatus deserves its own section, because it is the part most likely to actually reach you — and the part that is hardest to see through. A Facebook page called "Emma Davis", presenting itself as a "team of specialist in diabetes care and weight management" based in New South Wales, ran ads for a "GLP-1 plant based oral solution." The ad carried a testimonial from "Helen, 68, Sydney," who called it "one of the best gifts I've given myself in years," alongside before-and-after photographs that appeared to be AI-generated. The comment section was full of enthusiastic Australian women. Reverse image searches indicated their profile pictures were stolen from real people. One account, presenting as "Isla Taylor" of the Gold Coast, used a photograph of Agnieszka Pikulicka-Wilczewska, a Polish war correspondent, who confirmed to the Guardian that she had no idea her image was being used. Another profile used photos of three different women, including a guest columnist at an Ohio local newspaper and a former US television host. Then the part that should end any remaining doubt. The Maementcurves.com site claimed its product was "especially endorsed by Lyndi Cohen, one of Australia's leading dietitians." Cohen had never endorsed it. She told Guardian Australia her likeness was "being abused and misrepresented" to promote a product she would "obviously not endorse." Her team sent a cease and desist letter and heard nothing back. Her comment is the most honest description of this problem we have read: "It feels like international waters in a way, there's no jurisdiction. Whose job is it to control and manage this?"

Apply this backwards to your own experience of these ads. The professional-looking credential, the warm testimonial from a woman your age in your city, the before-and-after photos, the comment section full of people saying it worked, the named dietitian's endorsement — every one of those elements, in the case the Guardian documented, was fabricated. A comment section is not evidence. A named expert endorsement is not evidence unless you can find that expert saying it themselves, on their own channel.

What Three Regulators Say

This is not one newspaper's finding. Medicines regulators on three continents have issued warnings about this category, and their language is unusually direct. Australia's Therapeutic Goods Administration, asked about the UNSW analysis, urged consumers to "exercise extreme caution," warning that "prescription medicines purchased online may contain undisclosed harmful ingredients or may be counterfeit/fake," and advising strongly against using prescription medication "offered or issued without a valid prescription and consultation with a health practitioner." Counterfeit therapeutic goods, it noted, cannot lawfully be imported, advertised or supplied, and will be seized and destroyed at the border. Switzerland's Swissmedic has issued its own public warning about counterfeit and misleading "GLP-1" weight-reduction products sold online. The US Food and Drug Administration maintains a standing page on unapproved GLP-1 drugs. Its warnings about illegal online sales state that such products "may be counterfeit," "could contain the wrong ingredients or harmful ingredients," and "could contain too little, too much or no active ingredient at all." The FDA has issued warning letters to stop distribution of illegally marketed semaglutide and tirzepatide, and urges consumers to purchase only from state-licensed pharmacies. The FDA also flags two adjacent traps worth knowing about:
  • "Research purposes" / "not for human consumption" peptides. FDA has warned companies illegally selling unapproved semaglutide, tirzepatide and retatrutide under these labels — sold directly to consumers for human use, with dosing instructions. The label is a legal fig leaf, not a description.
  • Salt forms. Some compounders have used semaglutide sodium or semaglutide acetate. FDA states these are different active ingredients from the approved drug, and that it is not aware of any lawful basis for their use in compounding.
  • Counterfeit Ozempic has been found in the US drug supply chain, which is why pharmacy sourcing matters even for the real product.
  • Adverse events are real and accumulating: as of May 31, 2026, FDA had received 990 reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide — figures the agency notes are likely underreported.

The National Association of Boards of Pharmacy has reported on how illegal online sellers exploit demand for these drugs by offering substandard and falsified GLP-1 agonists. If you are buying online, the NABP maintains standards for legitimate internet pharmacies — and a site that will sell you a GLP-1 with no prescription and no consultation has already told you which category it is in.

Why an Oral GLP-1 Drop Cannot Work Anyway

Set the fraud aside for a moment. Suppose a bottle of GLP-1 drops genuinely contained GLP-1. It still would not work, and the reason is worth understanding because it inoculates you against the next version of this product. GLP-1 is a peptide, and peptides are food. Swallow a peptide and your digestive system does what it does to every protein you eat: gastric acid denatures it and proteases cut it into fragments. Almost nothing reaches your bloodstream intact. Native GLP-1 also has a half-life of roughly two minutes, degraded by the enzyme DPP-4. Even injected, unmodified GLP-1 is gone almost immediately. That is precisely the problem semaglutide was engineered to solve — structural modification to resist DPP-4, plus albumin binding, giving it a half-life of about a week. An oral semaglutide product does exist, and what it took to make it work tells you everything. Rybelsus is a tablet, and it only achieves absorption because it is co-formulated with an absorption enhancer, SNAC, that transiently raises local gastric pH and permeability. Even then, bioavailability is on the order of 1%, and it must be taken on an empty stomach with no more than about half a glass of water, at least 30 minutes before eating or drinking anything else. That is what the pharmaceutical industry had to build to get a peptide across the gut wall. A dropper bottle of flavoured liquid, taken however you like, is not a smaller version of that achievement. There is no FDA-approved GLP-1 in drop form, and the delivery problem is the reason.

The same logic applies to the sublingual and "under the tongue" versions marketed as bypassing digestion. Sublingual absorption is real but is limited to small, lipophilic molecules — the mucosa under your tongue is not a peptide gateway. Semaglutide is a roughly 4,114-dalton peptide. It is not crossing that membrane in a therapeutic amount any more than it crosses skin, which we cover in our GLP-1 patches review.

How to Tell a Ghost Store in Ninety Seconds

These operations rotate names faster than any review site can track them, so the durable protection is a checklist rather than a blocklist. Every item below is drawn from something the Guardian actually documented.
  • Read the terms of service and the privacy policy, and look for the operating company. In the Greatrfg case the site flew an Australian flag while its own terms named a Hong Kong operator. This one check takes thirty seconds and catches most of them.
  • Look for a real physical address and a working contact route. A CBD office tower used as a return address, or an email that bounces with a server error, is the answer.
  • Reverse image search a testimonial photo and a before-and-after. Fabricated before-and-afters and stolen profile pictures were central to the documented campaign.
  • Check any named expert endorsement at the source. If a dietitian or doctor is credited, find them saying it on their own site or channel. Lyndi Cohen's name was used entirely without her consent.
  • Distrust internal consistency failures. "Made in Australia" on the website and "made in the USA" on the box is not a translation error.
  • Treat regulator name-drops as claims, not credentials. "FDA approved" and "TGA approved" appeared on products that were neither. Both agencies publish searchable registers — a genuine approval is verifiable in a minute.
  • Search the product image, not the brand name. If the same green box appears under ten unrelated brands across Amazon, eBay and AliExpress, the brand is a sticker.
  • If it will sell you a prescription-class medicine with no prescription and no consultation, stop. That is disqualifying on its own, regardless of how professional the site looks.

If you have already bought one of these: dispute the charge with your card issuer rather than the seller, since a storefront that vanishes will not process your refund. Keep the packaging and screenshots of the listing. In the US you can report to the FDA via MedWatch and to the FTC at reportfraud.ftc.gov; in Australia to the TGA and Scamwatch. And if you took any of it and felt unwell, tell a clinician what you took and show them the bottle — "benign" was a finding about one tested sample, not a property of the category.

Frequently Asked Questions

Does GLP-1 oral liquid work for weight loss? There is no FDA-approved GLP-1 medication in drop or oral-liquid form. When UNSW chemists analysed a sample of one such product for Guardian Australia, they found no GLP-1 and no identifiable drug molecules — only preservatives in a salty solution that resembled eye drops. What was actually in the bottle that was tested? Small concentrations of methylparaben and benzenesulfonic acid, both common preservatives, in a very salty solution. Dr Jake Violi of UNSW described it as "basically salty water." Is it dangerous? The tested sample was benign, and the researcher was explicit that this was lucky rather than reassuring — his concern was that such a product "could have contained anything." There is no manufacturing oversight behind these items, so one clean result does not generalise to the next bottle or the next seller. What about "GLP-1 six in one oral liquid" and similar names? We have not tested those specific products and are not making claims about each brand individually. What we can say is that they share the marketing pattern, packaging and distribution channels described in the Guardian's investigation, and that no oral GLP-1 drop has regulatory approval anywhere. Apply the checklist above. Is there any legitimate oral GLP-1? Yes — Rybelsus, an oral semaglutide tablet, taken by prescription. It works only because it is co-formulated with the absorption enhancer SNAC, its bioavailability is around 1%, and it must be taken on an empty stomach with a small amount of water well before eating. That is a very different thing from drops. Why can't you just swallow GLP-1? Because it is a peptide. Stomach acid and digestive proteases break peptides into fragments, and native GLP-1 has a half-life of about two minutes even once absorbed. The reviews are four and five stars. Doesn't that mean something? In the documented case, the enthusiastic commenters were fake profiles using photographs stolen from real people, including a Polish war correspondent, and the before-and-after images appeared to be AI-generated. Ratings on marketplace listings for products like these are not a reliable signal. A dietitian endorsed it on the site. Is that not credible? Check it at the source. The dietitian named on one of these sites, Lyndi Cohen, had never endorsed the product, said her likeness was "being abused and misrepresented," and sent a cease and desist letter that went unanswered. What should I do instead? Talk to a clinician about whether GLP-1 therapy is appropriate for you, and obtain it through a licensed pharmacy with a real prescription. Our comparison of online GLP-1 programs covers legitimate providers and what supervised treatment costs.

The Bottom Line

Our rating: 1.0 / 10. This is the lowest rating we have ever given, and it is the only product category we have reviewed where the rating is not really about the product. It is about whether there is a product at all. Chemists at the University of New South Wales analysed a bottle of "STDEI GLP-1 Weight Loss Oral Liquid" for Guardian Australia and found no GLP-1 and no other identifiable drug molecules — only trace preservatives in a saline solution that, in Dr Jake Violi's words, appeared to be "simply eye drops or some similar product." His conclusion was not hedged: "it's basically salty water. Clearly, the sale of such products is a scam." And his warning was that the harmlessness was luck — the product "could have contained anything." Everything around it matched. A storefront claiming to be an Australian family business, shipping a box stamped "made in the USA" and "FDA approved." A sister site flying an Australian flag while its own terms named a Hong Kong operator, and an email address that bounced. Testimonials from people who do not exist, illustrated with photographs stolen from a Polish war correspondent and an Ohio newspaper columnist, and before-and-after images that appeared to be AI-generated. A named endorsement from a dietitian, Lyndi Cohen, who had never endorsed it, whose cease and desist letter was ignored, and whose question — *"Whose job is it to control and manage this?"* — is still unanswered. Three regulators have said their piece. The TGA urges "extreme caution" and seizes counterfeits at the border. Swissmedic has warned about counterfeit and misleading GLP-1 products. The FDA warns that illegally marketed versions "could contain too little, too much or no active ingredient at all," has issued warning letters over "research purposes" peptides including retatrutide, and had logged 990 adverse event reports for compounded semaglutide and more than 730 for tirzepatide as of May 31, 2026. And even a perfectly honest version of this product could not work. GLP-1 is a peptide; swallowing it is eating it. The one approved oral semaglutide needs an absorption enhancer, achieves roughly 1% bioavailability, and comes with strict fasting instructions. A dropper bottle is not a compact version of that. There is nothing to buy here. If you cannot afford prescription GLP-1 therapy, the answer is a licensed provider and an honest conversation about cost — not a green box from a storefront that will not exist next month.

Sources & References

Medical Disclaimer

This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.

Related Articles

Best GLP-1 Supplements 2026: We Reviewed Ten. Here's the Ranking.

Read more

GLP-1 Patches Review: Semaglutide Is 4,114 Daltons. Skin Stops at 500.

Read more

GLP-1 SOS Review: A Constipation Remedy With Iron In It

Read more
Back to All Articles